ISLAMABAD: A recent report by the Drug Regulatory Authority of Pakistan (DRAP) has uncovered a sharp and alarming increase in the prices of several commonly used medicines, raising concerns among patients and healthcare providers.
According to the report, the price of Coldrex tablets has surged by a record 1621%, with a pack that previously cost Rs 27 now being sold for Rs 475.
Medicines used for bone health, such as Kalv, have increased by 302%, while the widely used pain relief cream Brufen has become more than 244% more expensive.
Similarly, the price of the well-known eye ointment Polyfax has risen from Rs 34 to Rs 113.
For stomach and intestinal issues, Librax has seen a 241% increase in price, while allergy injection Avil has jumped from Rs 432 to Rs 1,500.
Laxatives such as Laxoberon have also become significantly costlier, with price hikes reaching up to 200%.
In addition, Stemetil, commonly used for nausea and dizziness, has become 188% more expensive.
The report highlights widespread inflation in pharmaceutical products, sparking concerns over affordability and access to essential medicines for the general public.
NEW DELHI: Several Bollywood celebrities and prominent public figures have expressed support for educationist and…
GUJRANWALA: A local court in Gujranwala summoned Jamiat Ulema-e-Islam (JUI) chief Maulana Fazlur Rehman while hearing…
ISLAMABAD: Solar panel prices in Pakistan remain stable, offering relief to households and businesses planning…
LAHORE: The National Savings Center has announced the results of the 107th draw of the…
ISLAMABAD: Pakistanis who are going abroad to find a job should avoid fraud, never pay…
ISLAMABAD: Advisor to the Ministry of Finance Khurram Shahzad has said that Pakistan has repaid…